Philips' Direct-to-Angio Stroke Pathway: New Analysis Demonstrates Substantial Cost Savings in Addition to Improved Patient Outcomes
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of a health economic analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an innovative approach to the stroke care pathway reduced costs by an average of EUR 2,848 (~USD 3,120) per patient. The retrospective analysis looked at data from the controlled single-center ANGIOCAT clinical trial conducted at the Vall d’Hebron University Hospital Stroke Unit (Barcelona, Spain)
Read more ...
Some Challenges in the NHS Acute Tech Market: and How to Navigate Them
NHS trusts need a lot of technology, but they face complex, structural challenges when it comes to procurement, and these tend to work against smaller companies and innovation. The Highland Marketing advisory board met recently to discuss the issues and the role of marketing.
Read more ...
AI System Predicts Consequences of Gene Modifications
Researchers at Gladstone Institutes, the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute have turned to artificial intelligence (AI) to help them understand how large networks of interconnected human genes control the function of cells, and how disruptions in those networks cause disease.
Read more ...
Philips and Masimo Introduce New, Advanced Monitoring Capabilities to Philips High Acuity Patient Monitors
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, today announced FDA clearance allowing the activation of SedLine® Brain Function Monitoring, Regional Oximetry (O3®), and CO2 measurements in Philips Patient Monitors - IntelliVue MX750 and MX850.
Read more ...
South Tees Clinicians Realise Immediate Impact from Miya Noting
Nurses and doctors at South Tees Hospitals NHS Foundation Trust have remarked on substantial time savings and safer ways of working, just hours after the go-live of a new digital noting solution.
The deployment of Miya Noting is an important part of the trust's electronic patient record programme, which is responding to urgent priorities faced by clinical teams through the Alcidion modular EPR, Miya Precision.
Clinisys Acquires Promium to Further Grow Scientific, Environmental and Public Health Diagnostics Capabilities
Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated to supporting environmental, water, wastewater and other analytical testing laboratories that protect health and safety.
Read more ...
Siemens Healthineers Invests 80 Million Euros in New Semiconductor Factory in Forchheim
Siemens Healthineers is building a new factory in Forchheim for the cultivation of crystals for semiconductor production. The total investment amounts to 80 million euros. The new factory is expected to create 100 new jobs. The existing production facility in Japan is reaching its capacity limits. The crystals are used as detector material for the latest generation of CT scanners.
Read more ...